Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers

BMC Cancer
Joanna VermeijJacques De Grève

Abstract

The status of the EGFR and HER2-neu genes has not been fully defined in ovarian cancer. An integrated analysis of both genes could help define the proportion of patients that would potentially benefit from targeted therapies. We determined the tumour mutation status of the entire tyrosine kinase (TK) domain of the EGFR and HER2-neu genes in a cohort of 52 patients with invasive epithelial ovarian cancer as well as the gene copy number and protein expression of both genes in 31 of these patients by DGGE and direct sequecing, immunohistochemistry and Fluorescent in Situ Hybridisation (FISH). The EGFR was expressed in 59% of the cases, with a 2+/3+ staining intensity in 38%. HER2-neu expression was found in 35%, with a 2/3+ staining in 18%. No mutations were found in exons 18-24 of the TK domains of EGFR and HER2-neu. High polysomy of the EGFR gene was observed in 13% of the invasive epthelial cancers and amplification of the HER2-neu gene was found in 10% and correlated with a high expression level by immunohistochemistry.Mutations within the tyrosine kinase domain were not found in the entire TK domain of both genes, but have been found in very rare cases by others. Genomic alteration of the HER2-neu and EGFR genes is frequent (...Continue Reading

References

Mar 11, 2000·Journal of Receptor and Signal Transduction Research·A D EbertD S Salomon
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Oct 1, 2004·Nature·Philip StephensMichael R Stratton
Dec 2, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J S NielsenA Jakobsen
Mar 9, 2005·Cancer Research·Hisayuki ShigematsuAdi F Gazdar
Mar 23, 2005·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Cheng-Han LeeC Blake Gilks
Apr 16, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jinru ShiaBeiyun Chen
May 5, 2005·Journal of the National Cancer Institute·Federico CappuzzoMarileila Varella-Garcia
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 15, 2005·The New England Journal of Medicine·Ming-Sound TsaoFrances A Shepherd
Jul 15, 2005·The New England Journal of Medicine·Zenta TsuchihashiPasi A Jänne
Jul 30, 2005·Molecular Endocrinology·Marco ContiYou-Qiang Su
Nov 12, 2005·The New England Journal of Medicine·Ingo K MellinghoffPaul S Mischel
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amanda PsyrriMeletios A Dimopoulos
Mar 24, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sylvia StadlmannGad Singer
Apr 12, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Heini LassusRalf Butzow
May 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hongbin JiKwok-Kin Wong
Jun 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueToshihiro Nukiwa
Feb 21, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K D SteffensenA Jakobsen

❮ Previous
Next ❯

Citations

Aug 31, 2013·PLoS Computational Biology·Harish ShankaranHaluk Resat
May 27, 2014·Journal of Photochemistry and Photobiology. B, Biology·Supriya SrinivasanAnthony J McGoron
Jul 24, 2014·Future Oncology·Vittoria MartinMilo Frattini
Aug 11, 2010·Expert Opinion on Biological Therapy·Lukas C Amler
Mar 17, 2012·Pathology, Research and Practice·Parvin Mahzouni, Mohammad Movahedipour
Mar 26, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Mark Murphy, Britta Stordal
Feb 2, 2012·International Journal of Breast Cancer·Gabriel L Fiszman, María A Jasnis
Dec 16, 2004·International Review of Cytology·Hitoshi Okamura, Hidetaka Katabuchi
Jun 19, 2009·Nature Reviews. Cancer·José Baselga, Sandra M Swain
May 18, 2019·International Journal of Molecular Sciences·Evgeniya A SokolovaSergey M Deyev
Nov 10, 2013·Cancers·Babu V SajeshKirk J McManus
Jun 4, 2013·The Oncologist·Melissa RooneyRamaswamy Govindan
Sep 13, 2012·Experimental and Therapeutic Medicine·Verena EngelstaedterDoris Mayr
May 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Annett HölskenRolf Buslei
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christina M AnnunziataElise C Kohn

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
PCR
Fluorescence
dissection

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Heini LassusRalf Butzow
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Sylvia StadlmannGad Singer
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
Evangelos TsiambasPetros Karakitsos
© 2021 Meta ULC. All rights reserved